Inventor · disambiguated record
Peter H. Seeberger
Also filed as: SEEBERGER PETER · SEEBERGER PETER H
38 granted patents·15 pending applications·211 citations·filing 1999–2023
97Inventor score
Files withMAX PLANCK GESELLSCHAFT16MASSACHUSETTS INST TECHNOLOGY10SEEBERGER PETER H5MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V4UNIV JIANGNAN3
Top patents by PatentIndex Score
53 records- 0193US8273357B2Antigen-carbohydrate conjugatesHACOHEN NIR·Filed 2005·Granted Sep 25, 2012·39 cites·49 claims
- 0287US6693178B2Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial librariesMASSACHUSETTS INST TECHNOLOGY·Filed 2002·Granted Feb 17, 2004·23 cites·10 claims
- 0385US7160517B2Apparatus and methods for the automated synthesis of oligosaccharidesMASSACHUSETTS INST OF TECHNOLG·Filed 2001·Granted Jan 9, 2007·31 cites·28 claims
- 0484US10220083B2Vaccines against Streptococcus pneumoniae serotype 8MAX PLANCK GESELLSCHAFT·Filed 2015·Granted Mar 5, 2019·9 cites·25 claims
- 0583US6846917B2Solid- and solution-phase synthesis of heparin and other glycosaminoglycansMASSACHUSETTS INST TECHNOLOGY·Filed 2002·Granted Jan 25, 2005·27 cites·25 claims
- 0680US10864261B2Synthetic vaccines against Streptococcus pneumoniae serotype 2MAX PLANCK GESELLSCHAFT·Filed 2016·Granted Dec 15, 2020·2 cites·17 claims
- 0780US10596272B2Vaccines against Streptococcus pneumoniae serotype 5MAX PLANCK GESELLSCHAFT·Filed 2016·Granted Mar 24, 2020·2 cites·21 claims
- 0880US9815889B2Antibodies for prevention and treatment of diseases caused by clostridium difficileMAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WSS E V·Filed 2015·Granted Nov 14, 2017·3 cites·4 claims
- 0979US10512605B2Integrated nano system for liver-targeting co-delivery of genes/drugs and preparation methodUNIV JIANGNAN·Filed 2018·Granted Dec 24, 2019·1 cites·9 claims
- 1079US6579725B1Linkers for synthesis of oligosaccharides on solid supportsMASSACHUSETTS INST TECHNOLOGY·Filed 2000·Granted Jun 17, 2003·18 cites·24 claims
- 1177US11191822B2Pneumococcal polysaccharide-protein conjugate compositionMAX PLANCK GESELLSCHAFT·Filed 2017·Granted Dec 7, 2021·2 cites·18 claims
- 1276US7102023B2Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial librariesMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted Sep 5, 2006·5 cites·4 claims
- 1375US10328141B2Synthetic vaccines against Streptococcus pneumoniae type 1MAX PLANCK GESELLSCHAFT·Filed 2014·Granted Jun 25, 2019·3 cites·7 claims
- 1475US8617819B2Polymers for analyte detectionSWAGER TIMOTHY M·Filed 2005·Granted Dec 31, 2013·4 cites·13 claims
- 1574US9238669B2Oligosaccharides and oligosaccharide-protein conjugates derived from Clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic toolsSEEBERGER PETER H·Filed 2012·Granted Jan 19, 2016·5 cites·2 claims
- 1673US7211663B2Synthesis of oligosaccharides, reagents and methods related theretoMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted May 1, 2007·4 cites·10 claims
- 1773US6426421B1Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial librariesMASSACHUSETTS INST TECHNOLOGY·Filed 2000·Granted Jul 30, 2002·4 cites·24 claims
- 1872US10359398B2Method for determining carbohydrates structureMAX PLANCK GESELLSCHAFT·Filed 2015·Granted Jul 23, 2019·2 cites·15 claims
- 1972US10052373B2Protein and peptide-free synthetic vaccines against Streptococcus pneumoniae type 3MAX PLANCK GESELLSCHAFT·Filed 2014·Granted Aug 21, 2018·3 cites·18 claims
- 2065US9150535B2Method and device for the synthesis of artemisininSEEBERGER PETER H·Filed 2012·Granted Oct 6, 2015·1 cites·12 claims
- 2164US7943594B2Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycansMASSACHUSETTS INST TECHNOLOGY·Filed 2003·Granted May 17, 2011·1 cites·18 claims
- 2264US6323339B1Synthesis of oligosaccharides, reagents and methods related theretoMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Nov 27, 2001·22 cites·19 claims
- 2362US2024286991A1Continuous flow process for production of cationic lipidsMAX PLANCK GESELLSCHAFT·Filed 2023·Application pending·0 cites
- 2456US7901687B2Antibodies for the detection of Bacillus anthracis and vaccine against B. anthracis infectionsETH ZUERICH·Filed 2007·Granted Mar 8, 2011·0 cites·4 claims
- 2554US10669353B2Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharideUNIV JIANGNAN·Filed 2018·Granted Jun 2, 2020·0 cites·11 claims
- 2654US2021292296A11,2,4-Trioxane compounds and compositions comprising the same for use in the treatment of COVID-19Artemiflow GmbH·Filed 2020·Application pending·0 cites
- 2753US2022380485A1Single domain antibodies specifically binding globo - series glycansMAX PLANCK GESELLSCHAFT·Filed 2020·Application pending·0 cites
- 2853US2007265441A1Apparatus and methods for the automated synthesis of oligosaccharidesMASSACHUSETTS INST TECHNOLOGY·Filed 2007·Application pending·0 cites
- 2952US11772063B2Method and device for producing saccharides and saccharide arraysMAX PLANCK GESELLSCHAFT·Filed 2019·Granted Oct 3, 2023·0 cites·15 claims
- 3051US10851130B2Chemical synthesis method of Plesiomonas shigelloides serotype O51 O-antigen oligosaccharideUNIV JIANGNAN·Filed 2018·Granted Dec 1, 2020·0 cites·15 claims
- 3151US2003232452A1Linkers for synthesis of oligosaccharides on solid supportsFiled 2003·Application pending·0 cites
- 3251US2003232978A1Reagents that facilitate the purification of compounds synthesized on a solid supportFiled 2002·Application pending·0 cites
- 3348US11014952B2Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines against Haemophilus influenzae type bMAX PLANCK GESELLSCHAFT·Filed 2017·Granted May 25, 2021·0 cites·8 claims
- 3448US9409142B2Method and device for the synthesis of artemisininMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V·Filed 2015·Granted Aug 9, 2016·0 cites·10 claims
- 3548US2011313148A1Automated oligosaccharide synthesizerCHRIST WILLIAM·Filed 2009·Application pending·0 cites
- 3647US2005221337A1Microarrays and microspheres comprising oligosaccharides, complex carbohydrates or glycoproteinsMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Application pending·0 cites
- 3746US9802974B2Synthesis of diverse glycosylphosphatidylinositol glycans from Toxoplasma gondii and their application as vaccines and diagnosticsMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V·Filed 2013·Granted Oct 31, 2017·0 cites·10 claims
- 3846US2012003260A1Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol GlycansSEEBERGER PETER H·Filed 2011·Application pending·0 cites
- 3945US2023149346A11,2,4-trioxane compounds and compositions comprising the same for use in the prevention and treatment of cancerArtemiflow GmbH·Filed 2021·Application pending·0 cites
- 4044US9676735B2Process for the preparation of efavirenz and devices suitable thereforeMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V·Filed 2015·Granted Jun 13, 2017·0 cites·19 claims
- 4143US12485401B2Synthesizer for oligo- and polysaccharides on solid phaseMAX PLANCK GESELLSCHAFT·Filed 2020·Granted Dec 2, 2025·0 cites·15 claims
- 4243US9802952B2Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivativesMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V·Filed 2014·Granted Oct 31, 2017·0 cites·19 claims
- 4343US2005187381A1Solid- and solution-phase synthesis of heparin and other glycosaminoglycansFiled 2005·Application pending·0 cites
- 4441US8536153B2Chemical synthesis of phosphatidylinositol mannoside glycans from Mycobacterium tuberculosisSEEBERGER PETER H·Filed 2009·Granted Sep 17, 2013·0 cites·13 claims
- 4539US2014234364A1Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidisMAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V·Filed 2012·Application pending·0 cites
- 4634US10688169B2Vaccines against carbapenem-resistant Klebsiella pneumoniaeMAX PLANCK GESELLSCHAFT·Filed 2016·Granted Jun 23, 2020·0 cites·11 claims
- 4733US8921444B2Process for the modification of polymers, in particular polymer nanoparticlesSEEBERGER PETER·Filed 2011·Granted Dec 30, 2014·0 cites·15 claims
- 4833US2013344104A1Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide ps-ii, methods of synthesis and uses thereof, in particular as a vaccineSEEBERGER PETER H·Filed 2012·Application pending·0 cites
- 4932US10588962B2Carbohydrate-glycolipid conjugate vaccinesMAX PLANCK GESELLSCHAFT·Filed 2013·Granted Mar 17, 2020·0 cites·12 claims
- 5032US10188718B2Vaccines against Streptococcus pneumoniae serotype 4MAX PLANCK GESELLSCHAFT·Filed 2015·Granted Jan 29, 2019·0 cites·25 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter H. Seeberger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →